These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27390143)

  • 1. Monogenic diabetes: Implementation of translational genomic research towards precision medicine.
    Vaxillaire M; Froguel P
    J Diabetes; 2016 Nov; 8(6):782-795. PubMed ID: 27390143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis.
    Vaxillaire M; Bonnefond A; Froguel P
    Best Pract Res Clin Endocrinol Metab; 2012 Apr; 26(2):171-87. PubMed ID: 22498247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young.
    Vaxillaire M; Froguel P; Bonnefond A
    Curr Diab Rep; 2019 Aug; 19(9):79. PubMed ID: 31385057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and clinical characteristics of maturity-onset diabetes of the young.
    Giuffrida FM; Reis AF
    Diabetes Obes Metab; 2005 Jul; 7(4):318-26. PubMed ID: 15955117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes.
    Vaxillaire M; D P; Bonnefond A; Froguel P
    Pediatr Endocrinol Rev; 2009 Mar; 6(3):405-17. PubMed ID: 19396026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision Diabetes Is Slowly Becoming a Reality.
    Mohan V; Radha V
    Med Princ Pract; 2019; 28(1):1-9. PubMed ID: 30685765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes.
    Yeung RO; Hannah-Shmouni F; Niederhoffer K; Walker MA
    Rev Endocr Metab Disord; 2018 Mar; 19(1):35-52. PubMed ID: 29777474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling.
    Dabi YT; Degechisa ST
    Diabetes Metab Syndr Obes; 2022; 15():1785-1797. PubMed ID: 35719247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine in diabetes mellitus: current opportunities and future prospects.
    Kleinberger JW; Pollin TI
    Ann N Y Acad Sci; 2015 Jun; 1346(1):45-56. PubMed ID: 25907167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Monogenic Diabetes: Present Clinical Challenges.
    Misra S; Owen KR
    Curr Diab Rep; 2018 Oct; 18(12):141. PubMed ID: 30377832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetics of monogenic forms of diabetes].
    Staník J; Hucková M; Staníková D; Masindová I; Valentínová L; Gasperíková D; Klimes I
    Vnitr Lek; 2011 Nov; 57(11):937-45. PubMed ID: 22165700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling different types of diabetes using human pluripotent stem cells.
    Abdelalim EM
    Cell Mol Life Sci; 2021 Mar; 78(6):2459-2483. PubMed ID: 33242105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Editing Human Pluripotent Stem Cells to Model β-Cell Disease and Unmask Novel Genetic Modifiers.
    George MN; Leavens KF; Gadue P
    Front Endocrinol (Lausanne); 2021; 12():682625. PubMed ID: 34149620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?
    Timsit J; Saint-Martin C; Dubois-Laforgue D; Bellanné-Chantelot C
    Can J Diabetes; 2016 Oct; 40(5):455-461. PubMed ID: 27103109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monogenic diabetes : a pioneer in precision medicine management].
    Iafrate-Luterbacher F; Dirlewanger M; Hauschild M; Schwitzgebel VM; Busiah K
    Rev Med Suisse; 2023 Feb; 19(815):362-367. PubMed ID: 36815326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturity-Onset Diabetes of the Young (MODY): Making the Right Diagnosis to Optimize Treatment.
    Amed S; Oram R
    Can J Diabetes; 2016 Oct; 40(5):449-454. PubMed ID: 27130141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Factors of Diabetes.
    Antosik K; Borowiec M
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):157-160. PubMed ID: 28083605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision diabetes: learning from monogenic diabetes.
    Hattersley AT; Patel KA
    Diabetologia; 2017 May; 60(5):769-777. PubMed ID: 28314945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review on monogenic diabetes.
    Steck AK; Winter WE
    Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):252-8. PubMed ID: 21844708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.